Results 91 to 100 of about 529,428 (208)

Peripheral targets for neuropathic pain

open access: yesBritish Journal of Pharmacology, EarlyView.
Neuropathic pain represents a significant clinical challenge, with still limited pharmacological approaches to symptomatic relief. This review focuses on molecular targets implicated in neuropathic pain, particularly those involved in peripheral mechanisms. Using the IUPHAR/BPS database of biological targets, their occurrence together with ‘neuropathic
Amirhossein Afsharipour   +3 more
wiley   +1 more source

Don’t stress: a case report of regional anesthesia as the primary anesthetic for gynecologic surgery in a patient with mitochondrial myopathy and possible malignant hyperthermia susceptibility

open access: yesBMC Anesthesiology, 2019
Background We aim to describe the evaluation and management of a patient with the uncommon combination of both mitochondrial myopathy and possible malignant hyperthermia susceptibility as an important source of information and as a valuable example of ...
Marci B. Pepper   +2 more
doaj   +1 more source

Phototherapies mediated by metallic nanoparticles and near‐infrared radiation in skin cancer: A systematic review

open access: yesPhotochemistry and Photobiology, EarlyView.
Recent studies demonstrate that near‐infrared (NIR—750–980 nm)‐mediated photodynamic (PDT) and photothermal (PTT) therapies, combined with metallic nanoparticles (MNPs), show promising results against skin cancer, particularly melanoma, in both in vitro and in vivo models.
Tamyris Devincenzi   +3 more
wiley   +1 more source

European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility [PDF]

open access: yes, 2017
It is 30 yr since the British Journal of Anaesthesia published the first consensus protocol for the laboratory diagnosis of malignant hyperthermia susceptibility from the European Malignant Hyperthermia Group. This has subsequently been used in more than
Girard, T.   +23 more
core  

Rocuronium and Malignant Hyperthermia [PDF]

open access: yes, 2012
Authors response to a comment on: Beggs A, McCann J, Powers J. “Delayed-onset malignant hyperthermia in association with rocuronium use ” Am J Health-Syst Pharm 2012; 69:1128 ...
Beggs, Ashton E., McCann, Jennifer Quinn
core   +1 more source

Genetic Testing in Movement Disorders: Riding the Wave Without Being Swept Under

open access: yes
Movement Disorders, EarlyView.
Alessio Di Fonzo, Francesca Magrinelli
wiley   +1 more source

Engineering Catalytic Biomaterials for Cellular Fate Modulation

open access: yesAngewandte Chemie Novit, Volume 2, Issue 4, December 2026.
Catalytic biomaterials actively reprogram cell fate by converting endogenous biochemical cues or external stimuli into localized catalytic outputs. Through regulation of redox balance, organelle homeostasis, metal‐ion metabolism, and inflammatory signaling, they bidirectionally modulate regulated cell death and immune responses for disease treatment ...
Baoying Xu   +4 more
wiley   +1 more source

Gemtuzumab Ozogamicin for Patients with Newly Diagnosed CD33‐Positive Acute Myeloid Leukemia: A French Retrospective Observational Study

open access: yeseJHaem, Volume 7, Issue 6, December 2026.
ABSTRACT Introduction Gemtuzumab ozogamicin (GO), a CD33‐targeted antibody–drug conjugate, is approved in combination with daunorubicin/cytarabine for patients ≥ 15 years with de novo, CD33‐positive acute myeloid leukemia (AML). Methods This retrospective, observational study assessed real‐world use, clinical outcomes, and safety of GO in 113 patients ...
Juliette Lambert   +8 more
wiley   +1 more source

Knowledge of nursing professionals of a surgical center regarding malignant hyperthermia

open access: yesRevista Gaúcha de Enfermagem
The objective of this study was to assess the knowledge of the nursing professionals in a surgical center about malignant hyperthermia. This is a descriptive exploratory study on malignant hyperthermia conducted with mid- and high-level nursing ...
Cristina Silva Sousa   +1 more
doaj   +1 more source

Synergistic Regulation of Biomaterials and Macrophages: A Novel Paradigm in Immunotherapy

open access: yesMedComm – Biomaterials and Applications, Volume 5, Issue 4, December 2026.
Bioengineered materials mediating the modulation of macrophage plasticity and inflammatory signals in the tumor microenvironment effectively remodel immunoregulatory states, boost antitumor immunity, and promote tissue repair, achieving synergistic therapeutic outcomes.
Jiayu Zhang   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy